1. |
王琳, 刘爱兵. 适合人肌母细胞的无血清培养基. 中国组织工程, 2015, 19(51):8271-8275.
|
2. |
Peter K Law, Danlin M Law, Ping Lu, et al. Human myoblast genome therapy. J Geriatric Cardiology, 2006, 3(3):135-149.
|
3. |
Hecht N, Marushima A, Nieminen M, et al. Myoblast-mediated gene therapy improves functional collateralization in chronic cerebral hypoperfusion. Stroke, 2015, 46(1):203-211.
|
4. |
Pagani FD, DerSimonian H, Zawadzka A, et al. Autologous skeletal myoblast transplanted to ischemia-damaged myocardium in humans.Histological analysis of cell survival and diffierentiation. J Am Coll Cardiol, 2003, 41(5):879-888.
|
5. |
Ye L, Haider HKh, Tan R, et al. Transplantation of nanoparticle transfected skeletal myoblasts overexpressing vascular endothelial growth factor-165 for cardiac repair. Circulation, 2007, 116(11 Suppl):113-120.
|
6. |
Ye L, Haider HKh, Jiang S, et al. Improved angiogenic response in pig heart following ischaemic injury using human skeletal myoblast simultaneously expressing VEGF165 and angiopoietin-1. Eur J Heart Fail, 2007, 9(1):15-22.
|
7. |
Ye L, Lee KO, Su LP, et al. Skeletal myoblast transplantation for attenuation of hyperglycaemia, hyperinsulinaemia and glucose intolerance in a mouse model of type 2 diabetes mellitus. Diabetologia, 2009, 52(9):1925-1934.
|
8. |
Cheng Q, Law PK, de Gasparo M, et al. Combination of the dipeptidyl peptidase IV inhibitor LAF237[(S)-1-[(3-hydroxy-1-adamantyl) ammo] acetyl-2-cyanopyrrolidine] with the angiotensin Ⅱ Type 1 receptor antagonist valsartan[N-(1-Oxopentyl)-N-[[2-(1H-tetrazol-5-yl)-[1,1-biphenyl]-4-yl]methyl]-L-valine] enhances pncreatic islet morphology and function in a mouse model of type 2 diabetes. J Pharmacol Exp Ther, 2008, 327(3):683-691.
|
9. |
秦瑞峰, 顾晓明, 黄富国, 等. 流式细胞术测定骨骼肌细胞分化中DNA合成及其细胞周期变化. 第四军医大学学报, 2000, 21(8):921-923.
|
10. |
秦瑞峰, 顾晓明, 张浩. 不同培养条件对骨骼肌细胞增殖及分化的影响. 实用口腔医学杂志, 2000, 16(1):14-16.
|
11. |
刘立斌, 周红雨. 成肌细胞的临床应用现状及前景. 中国修复重建外科杂志, 2007, 21(7):767-770.
|
12. |
刘宁, 刘雅南, 刘涛, 等. 硫酸软骨素的制备研究及发展现状. 食品工业科技, 2014, 35(3):392-395.
|
13. |
陈小宇, 刘成成, 祝爱珍, 等. 硫酸软硫骨素对3T3-L1细胞增殖和分化的影响. 中国医科大学学报, 2013, 42(7):599-603.
|
14. |
Haylock-Jacobs S, Keoμgh MB, Lau L, et al. Chondroitin sulphate proteoglycans:extracellular matrix proteins that regulate immunity of the central nervous system. Autoimmun Rev, 2011, 10(12):766-772.
|
15. |
Lee JY, Lee SH, Kim HJ, et al. The preventive inhibition of chondroitin sulfate against the CCl4-induced oxidative stress of subcellular level. Arch Pharm Res, 2004, 27(3):340-345.
|
16. |
Nishimoto S, Takagi M, Wakitani S, et al. Effect of chondroitin sulfate and hyaluronic acid on gene expression in a three-dimensional culture of chondrocytes. J Biosci Bioeng, 2005, 100(1):123-126.
|
17. |
Dubey L, Sharma M. Cardiogenic shock complicating acute myocardial infarction-a review. Acta Cardiol, 2011, 66(6):691-699.
|
18. |
Peters K, Kaufman M, Dmochowski L, et al. 1340 autologous muscle derived cell therapy for the treatment of female stress urinary incontinence:a multi-center experience. J Urol, 2011, 185(4):e535-536.
|
19. |
Baj A, Bettaccini AA, Casalone R, et al. Culture of skeletal myoblasts from human donors aged over 40 years:dynamics of cell growth and expression of differentiation markers. J Transl Med, 2005, 3(1):21.
|
20. |
Jarocha D, Stangel-Wojcikiewicz K, Basta A, et al. Efficient myoblast expansion for regenerative medicine use. Int J Mol Med, 2014, 34(1):83-91.
|